InVivoMab anti-mouse CD19 BE0150-R100mg from Bio X Cell

Product Specs
ItemInVivoMab anti-mouse CD19
CompanyBio X Cell
Price $4,651.50Supplier Page View Company Product Page
Catalog NumberBE0150-R100mg
Quantity100 mg
ApplicationsFlow Cytometry, in vivo Cell Specific Depletion, in vivo Neutralization & Blocking
ConcentrationLot-Specific
Conjugate/TagUnconjugated
FormatPBS, pH 7.0, Contains no stabilizers or preservatives, Liquid
Purity≥95% Determined by SDS-PAGE
ReactivityMouse
IsotypeIgG2a, κ
Clone1D3
Hostrat
Antibody TypePrimary Antibody
ImmunogenK562 cells expressing the extracellular domain of mouse CD19
NCBI Full Gene NameCD19 antigen
ClonalityMonoclonal
Research AreaCancer Biology, Immunology, Tumor Antigens, CD Markers
StorageThe antibody solution should be stored at the stock concentration at 4°C. Do not freeze
Molecular Weight150 kDa
ModificationsNo
OriginUnited States

Endotoxin: ≤1EU/mg (≤0.001EU/µg), Determined by LAL gel clotting assay

Quantities Available: 1mg, 5mg, 25mg,50mg, 100mg, Additional Custom Sizing Available on bioxcell.com

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bioxcell.com

(2) Transcription Factor Repertoire of Homeostatic EosinophilopoiesisJournal of immunology (Baltimore, Md. : 1950)September 15, 2015Bouffi C, Kartashov AV, Schollaert KL, Chen X, Bacon WC, Weirauch MT, Barski A, Fulkerson PC.

(3) Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunityNatureMay 7, 2015Carmi Y, Spitzer MH, Linde IL, Burt BM, Prestwood TR, Perlman N, Davidson MG, Kenkel JA, Segal E, Pusapati GV, et al.

(5) Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodiesClinical cancer research : an official journal of the American Association for Cancer ResearchMarch 1, 2015Dai M, Yip YY, Hellstrom I, Hellstrom KE.

(6) ADAM17 limits the expression of CSF1R on murine hematopoietic progenitorsExperimental hematologyJanuary 1, 2015Becker AM, Walcheck B, Bhattacharya D.

(7) T cell development requires constraint of the myeloid regulator C/EBP-α by the Notch target and transcriptional repressor Hes1Nature immunologyDecember 1, 2013De Obaldia ME, Bell JJ, Wang X, Harly C, Yashiro-Ohtani Y, DeLong JH, Zlotoff DA, Sultana DA, Pear WS, Bhandoola A.

(9) Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammationJournal of immunotherapy (Hagerstown, Md. : 1997)May 1, 2013Dai M, Wei H, Yip YY, Feng Q, He K, Popov V, Hellstrom I, Hellstrom KE.

(10) Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responsesProceedings of the National Academy of Sciences of the United States of AmericaApril 10, 2012Purtha WE, Swiecki M, Colonna M, Diamond MS, Bhattacharya D.

(11) Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutantsThe Journal of experimental medicineDecember 19, 2011Purtha WE, Tedder TF, Johnson S, Bhattacharya D, Diamond MS.

(12) B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in agingBloodMarch 17, 2011Keren Z, Naor S, Nussbaum S, Golan K, Itkin T, Sasaki Y, Schmidt-Supprian M, Lapidot T, Melamed D.

InVivoMab anti-mouse CD19